English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Wilson's disease (WD) is an autosomal recessive disorder in which copper metabolism is impaired. In fact, copper accumulates in various organs and tissues can be seen and causes toxic effects in various tissues including liver, brain, kidneys and eyes. Sulfur amino acid is a metabolite of D-penicillamine and penicillamine and copper Chlator is a factor that causes urinary excretion of copper and WD therapeutic agent as well. The interesting thing about the neurological symptoms of Wilson's disease with penicillamine is the drug may worsen or even in an asymptomatic patient, the treatment may be creating symptoms. DTPA is a pentavalent compound containing carboxylic DTPA is a chemical compound that is used in radiation therapy and MRI. It can give the metal chelate with iron, copper and other cations can be conjugated and also treatment of internal body pollution caused by various elements, including raDOIactive elements. DTPA could not be lonely absorbed by the cell. The goal is to conjugate it with the G2 Dendrimer (Nanosized anionic linear biocompatible polymer) to bring it to the nano size and increase the intracellular uptake compared to the ground state. Based on the hypothesis, nanoconjugated DTPA-Dendrimer G2 was synthesized and then evaluated on Hep G2 WD cell model in vitro and the results showed a good effectiveness without any toxicity for the conjugate in decreasing the intracellular copper level comparing to gold standard D-penicillamine respectively. Based on the findings the nanosized conjugate seems to have very good prognoses and clinical future and this needs to be further investigated.

Nano-scaled Diethylene Triamine Pent Acetic Acid (N-DTPA): Novel Anti-Wilson's Disease Cell Model